{"version":"1.0","provider_name":"All About Cardiovascular System and Disorders","provider_url":"https:\/\/johnsonfrancis.org\/professional","author_name":"Johnson Francis","author_url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/","title":"Biomarkers in acute pulmonary embolism - All About Cardiovascular System and Disorders","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"eIsPofsz0v\"><a href=\"https:\/\/johnsonfrancis.org\/professional\/biomarkers-in-acute-pulmonary-embolism\/\">Biomarkers in acute pulmonary embolism<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/johnsonfrancis.org\/professional\/biomarkers-in-acute-pulmonary-embolism\/embed\/#?secret=eIsPofsz0v\" width=\"600\" height=\"338\" title=\"&#8220;Biomarkers in acute pulmonary embolism&#8221; &#8212; All About Cardiovascular System and Disorders\" data-secret=\"eIsPofsz0v\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/johnsonfrancis.org\/professional\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2022\/06\/Biomarkers-in-acute-pulmonary-embolism.jpg","thumbnail_width":1207,"thumbnail_height":675,"description":"Biomarkers in acute pulmonary embolism Biomarkers of myocardial injury may be elevated in acute pulmonary embolism. They are due to right ventricular ischemia and can influence early outcome. Elevated cardiac troponins are associated with worse prognosis in acute pulmonary embolism. It is a supply demand mismatch as in type 2 myocardial infarction. Systemic hypotension reduces [&hellip;]"}